Nicotine Science and Policy

The EU’s delayed tobacco tax vote shows how contested the future of nicotine policy has become. Sweden’s election has turned timing into strategy, but the deeper question is whether Europe will tax according to risk or flatten cigarettes, vapes, pouches and heated tobacco into one category. A credible fiscal framework should keep combustible tobacco clearly less attractive than lower-risk alternatives. Tax policy can raise revenue, but it should not erase the incentives that help smokers move away from combustion.

The UK vaping duty risks weakening one of the clearest incentives for smokers to switch. Price signals matter: legal vapes need to remain more attractive than cigarettes and safer than the illicit market. A tax designed to raise revenue can still create public health costs when it makes lower-risk products harder to afford. Tobacco policy should discourage smoking without punishing the people who have already moved away from combustion.

Harm reduction feels different for smokers because tobacco control has often treated nicotine use as a moral problem rather than a risk continuum. People who smoke need realistic ways to reduce exposure to the harms of combustion, especially after repeated quit attempts. Safer nicotine products do not remove every risk, but they can change the scale of harm dramatically. Public health should meet smokers with practical options, not only expectations of abstinence.

Australia’s nicotine policy has become a case study in disinformation with real-world consequences. Smokers are told to quit, yet lower-risk alternatives are restricted, misrepresented or pushed into channels with less oversight. That confusion protects cigarettes more than it protects public health. Evidence-based communication should explain relative risk clearly, support adult switching and stop treating harm reduction as a threat to tobacco control.

A patient who still smokes is not a failure of character. It may be a sign that the advice, tools or assumptions around quitting are not meeting the reality of dependence. Clinicians can make a difference by asking what has already been tried, what keeps the cigarette in place, and whether lower-risk nicotine options could support a move away from combustion. Smoking cessation works better when care starts with the person, not the expectation that one method should work for everyone.